BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 28534138)

  • 1. A Chemically Modified Curcumin (CMC 2.24) Inhibits Nuclear Factor κB Activation and Inflammatory Bone Loss in Murine Models of LPS-Induced Experimental Periodontitis and Diabetes-Associated Natural Periodontitis.
    Elburki MS; Rossa C; Guimarães-Stabili MR; Lee HM; Curylofo-Zotti FA; Johnson F; Golub LM
    Inflammation; 2017 Aug; 40(4):1436-1449. PubMed ID: 28534138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel chemically modified curcumin reduces inflammation-mediated connective tissue breakdown in a rat model of diabetes: periodontal and systemic effects.
    Elburki MS; Moore DD; Terezakis NG; Zhang Y; Lee HM; Johnson F; Golub LM
    J Periodontal Res; 2017 Apr; 52(2):186-200. PubMed ID: 27038334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of natural Curcumin and chemically modified curcumin on inflammation and bone resorption in model of experimental periodontitis.
    Curylofo-Zotti FA; Elburki MS; Oliveira PA; Cerri PS; Santos LA; Lee HM; Johnson F; Golub LM; Rossa C; Guimarães-Stabili MR
    Arch Oral Biol; 2018 Jul; 91():42-50. PubMed ID: 29669267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel chemically modified curcumin reduces severity of experimental periodontal disease in rats: initial observations.
    Elburki MS; Rossa C; Guimaraes MR; Goodenough M; Lee HM; Curylofo FA; Zhang Y; Johnson F; Golub LM
    Mediators Inflamm; 2014; 2014():959471. PubMed ID: 25104884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent anti-inflammatory effects of systemically administered curcumin modulate periodontal disease in vivo.
    Guimarães MR; Coimbra LS; de Aquino SG; Spolidorio LC; Kirkwood KL; Rossa C
    J Periodontal Res; 2011 Apr; 46(2):269-79. PubMed ID: 21306385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A p38 mitogen-activated protein kinase inhibitor arrests active alveolar bone loss in a rat periodontitis model.
    Rogers JE; Li F; Coatney DD; Otremba J; Kriegl JM; Protter TA; Higgins LS; Medicherla S; Kirkwood KL
    J Periodontol; 2007 Oct; 78(10):1992-8. PubMed ID: 18062121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect and related mechanisms of curcumin in rat experimental periodontitis.
    Xiao CJ; Yu XJ; Xie JL; Liu S; Li S
    Head Face Med; 2018 Aug; 14(1):12. PubMed ID: 30115081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-response assessment of chemically modified curcumin in experimental periodontitis.
    de Almeida Brandão D; Spolidorio LC; Johnson F; Golub LM; Guimarães-Stabili MR; Rossa C
    J Periodontol; 2019 May; 90(5):535-545. PubMed ID: 30394523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of selective COX-2 inhibitor/celecoxib and omega-3 fatty acid on matrix metalloproteinases, TIMP-1, and laminin-5gamma2-chain immunolocalization in experimental periodontitis.
    Vardar-Sengul S; Buduneli E; Turkoglu O; Buduneli N; Atilla G; Wahlgren J; Sorsa T; Baylas H
    J Periodontol; 2008 Oct; 79(10):1934-41. PubMed ID: 18834249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced efficacy of chemically modified curcumin in experimental periodontitis: systemic implications.
    Wang HH; Lee HM; Raja V; Hou W; Iacono VJ; Scaduto J; Johnson F; Golub LM; Gu Y
    J Exp Pharmacol; 2019; 11():1-14. PubMed ID: 30774454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A p38alpha selective mitogen-activated protein kinase inhibitor prevents periodontal bone loss.
    Kirkwood KL; Li F; Rogers JE; Otremba J; Coatney DD; Kreider JM; D'Silva NJ; Chakravarty S; Dugar S; Higgins LS; Protter AA; Medicherla S
    J Pharmacol Exp Ther; 2007 Jan; 320(1):56-63. PubMed ID: 17041006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinases, tissue inhibitor of matrix metalloproteinase-1, and laminin-5 gamma2 chain immunolocalization in gingival tissue of endotoxin-induced periodontitis in rats: effects of low-dose doxycycline and alendronate.
    Buduneli E; Vardar-Sengül S; Buduneli N; Atilla G; Wahlgren J; Sorsa T
    J Periodontol; 2007 Jan; 78(1):127-34. PubMed ID: 17199549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin modulates the immune response associated with LPS-induced periodontal disease in rats.
    Guimarães MR; de Aquino SG; Coimbra LS; Spolidorio LC; Kirkwood KL; Rossa C
    Innate Immun; 2012 Feb; 18(1):155-63. PubMed ID: 21242275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Modified-Curcumin Promotes Resolvin-Like Activity and Reduces Bone Loss in Diabetes-Induced Experimental Periodontitis.
    Deng J; Golub LM; Lee HM; Raja V; Johnson F; Kucine A; Lee W; Xu TM; Gu Y
    J Inflamm Res; 2021; 14():5337-5347. PubMed ID: 34703272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-methoxycarbonyl curcumin: a unique inhibitor of both inflammatory mediators and periodontal inflammation.
    Gu Y; Lee HM; Napolitano N; Clemens M; Zhang Y; Sorsa T; Zhang Y; Johnson F; Golub LM
    Mediators Inflamm; 2013; 2013():329740. PubMed ID: 24453415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ginsenoside Rb3 Inhibits Pro-Inflammatory Cytokines via MAPK/AKT/NF-κB Pathways and Attenuates Rat Alveolar Bone Resorption in Response to
    Sun M; Ji Y; Li Z; Chen R; Zhou S; Liu C; Du M
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33092290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin prevents lipopolysaccharide-induced atrogin-1/MAFbx upregulation and muscle mass loss.
    Jin B; Li YP
    J Cell Biochem; 2007 Mar; 100(4):960-9. PubMed ID: 17131360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combination of a chemically modified doxycycline and a bisphosphonate synergistically inhibits endotoxin-induced periodontal breakdown in rats.
    Llavaneras A; Ramamurthy NS; Heikkilä P; Teronen O; Salo T; Rifkin BR; Ryan ME; Golub LM; Sorsa T
    J Periodontol; 2001 Aug; 72(8):1069-77. PubMed ID: 11525440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling pathways associated with the expression of inflammatory mediators activated during the course of two models of experimental periodontitis.
    Garcia de Aquino S; Manzolli Leite FR; Stach-Machado DR; Francisco da Silva JA; Spolidorio LC; Rossa C
    Life Sci; 2009 May; 84(21-22):745-54. PubMed ID: 19285515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical application of glycyrrhetinic acid in the gingival sulcus inhibits attachment loss in lipopolysaccharide-induced experimental periodontitis in rats.
    Takamori A; Yoshinaga Y; Ukai T; Nakamura H; Takamori Y; Izumi S; Shiraishi C; Hara Y
    J Periodontal Res; 2018 Jun; 53(3):422-429. PubMed ID: 29446076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.